disclosed herein are substituted fluoromethanes ; pharmaceutical compositions comprising a therapeutically effective amount of the same ; processes for preparing these fluoromethanes ; and methods of using the same in alleviating infection and parasitism . also disclosed are methods for identifying substituted fluoromethanes for modulating the activity of receptors and enzymes that bind and / or modify phosphate containing ligands and substrates .